Calcium antagonists in clinical medicine:
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Philadelphia
Hanley & Belfus u.a.
1992
|
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | VIII, 438 S. graph. Darst. |
| ISBN: | 1560530219 |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV009261363 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | t | ||
| 008 | 940324s1992 d||| |||| 00||| engod | ||
| 020 | |a 1560530219 |9 1-56053-021-9 | ||
| 035 | |a (OCoLC)28510750 | ||
| 035 | |a (DE-599)BVBBV009261363 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 |a DE-11 | ||
| 050 | 0 | |a RC684.C34 | |
| 082 | 0 | |a 616.1/061 |2 20 | |
| 084 | |a XI 4300 |0 (DE-625)153005:12905 |2 rvk | ||
| 245 | 1 | 0 | |a Calcium antagonists in clinical medicine |c Murray Epstein |
| 264 | 1 | |a Philadelphia |b Hanley & Belfus u.a. |c 1992 | |
| 300 | |a VIII, 438 S. |b graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 650 | 7 | |a Calciumantagonisten |2 gtt | |
| 650 | 7 | |a Klinische geneeskunde |2 gtt | |
| 650 | 4 | |a Calcium Channel Blockers |x metabolism | |
| 650 | 4 | |a Calcium Channel Blockers |x therapeutic use | |
| 650 | 4 | |a Calcium |x Antagonists |x Therapeutic use | |
| 650 | 4 | |a Heart Diseases |x drug therapy | |
| 650 | 0 | 7 | |a Calciumantagonist |0 (DE-588)4069807-5 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Calciumantagonist |0 (DE-588)4069807-5 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Epstein, Murray |e Sonstige |4 oth | |
| 856 | 4 | 2 | |m GBV Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=006163051&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-006163051 | ||
Datensatz im Suchindex
| _version_ | 1804123709499244544 |
|---|---|
| adam_text | CALCIUM ANTAGONISTS IN CLINICAL MEDICINE MURRAY EPSTEIN, M.D., F.A.C.P.
PROFESSOR OF MEDICINE UNIVERSITY OF MIAMI SCHOOL OF MEDICINE ATTENDING
PHYSICIAN VETERANS ADMINISTRATION MEDICAL CENTER JACKSON MEMORIAL
MEDICAL CENTER MIAMI, FLORIDA HANLEY & BELFUS, INC./PHILADELPHIA
MOSBY-YEAR BOOK, INC./ST. LOUIS * BALTIMORE * BOSTON CHICAGO * LONDON *
PHILADELPHIA * SYDNEY * TORONTO CONTENTS 1 BIOCHEMICAL AND
PHARMACOLOGICAL DIFFERENCES AMONG CALCIUM ANTAGONISTS: CLINICAL
IMPLICATIONS DAVID J. TRIGGLE, PH.D. 2 CALCIUM FUNCTION IN VASCULAR
SMOOTH MUSCLE AND ITS RELATIONSHIP TO HYPERTENSION 29 JEFFREY L. RAM,
PH.D. PAUL R. STANDLEY, M.S. JAMES R. SOWERS, M.D. 3 PHARMACOKINETICS OF
CALCIUM ANTAGONISTS: IMPLICATIONS FOR THERAPY .. 49 ANDREW D. MORRIS,
M.B, CH.B., M.R.C.P. PETER A. MEREDITH, B.SC, PH.D. JOHN L. REID, D.M.,
F.R.C.P. 4 HEMODYNAMIC EFFECTS OF CALCIUM ANTAGONISTS IN HYPERTENSION 69
PER LUND-JOHANSEN, M.D., PH.D. 5 ARTERIAL COMPLIANCE AND EFFECT OF
CALCIUM ANTAGONISTS 89 GERARD M. LONDON, M.D. MICHEL E. SAFAR, M.D.
BERNARD I. LEVY, M.D. 6 VASCULAR AND MYOCARDIAL RESPONSES TO CALCIUM
ANTAGONISTS: IMPLICATIONS FOR HYPERTENSION AND CONGESTIVE HEART FAILURE
105 ROBERT J. CODY, M.D. 7 CARDIAC EFFECTS OF CALCIUM ANTAGONISTS IN
HYPERTENSION 137 FRANZ H. MESSERLI, M.D. MARIO MCLOUGHLIN, M.D. 8
VASOPROTECTIVE EFFECTS OF CALCIUM ANTAGONISTS IN EXPERIMENTAL MODELS OF
ISCHEMIA 151 WINIFRED G. NAYLER, M.SC, D.SC. 9 PHARMACOTHERAPY OF
MYOCARDIAL INFARCTION: CURRENT PERSPECTIVES 165 CARLJ. PEPINE, M.D. 10
THE ANTIARRHYTHMIC EFFECTS OF CALCIUM ANTAGONISTS 183 GEORGE E. BILLMAN,
PH.D. III IV CONTENTS 11 CALCIUM ANTAGONISTS IN THE MANAGEMENT OF
HYPERTENSION 213 MURRAY EPSTEIN, M.D, F.A.C.P. 12 CALCIUM ANTAGONISTS
AND THE GASTROINTESTINAL TRACT: IMPLICATIONS FOR THERAPY 231 DAVID A.
KATZKA, M.D. DONALD 0. CASTELL, M.D. 13 CALCIUM ANTAGONISTS: POTENTIAL
ROLE IN PULMONARY DISEASES 243 TAHIR AHMED, M.D. ADAM WANNER, M.D. 14
CALCIUM ANTAGONISTS AND THE CEREBRAL CIRCULATION 265 HERMAN J. GELMERS,
M.D, PH.D. 15 INSULIN-GLUCOREGULATORY HORMONES: IMPLICATIONS FOR
ANTIHYPERTENSIVE THERAPY 291 DALILA B. CORRY, M.D. MICHAEL L. TUCK, M.D.
16 CALCIUM ANTAGONISTS AND THE KIDNEY: IMPLICATIONS FOR RENAL PROTECTION
309 MURRAY EPSTEIN, M.D, F.A.C.P. 17 NATRIURETIC EFFECTS OF CALCIUM
ANTAGONISTS 349 MURRAY EPSTEIN, M.D, F.A.C.P. ANNA G. DE MICHELI, M.D.
18 CALCIUM ABNORMALITIES AND THE DIABETIC, HYPERTENSIVE PATIENT:
IMPLICATIONS FOR RENAL PRESERVATION 367 GEORGE L. BAKRIS, M.D, F.A.C.P.
19 CLINICAL BENEFITS OF CALCIUM ANTAGONISTS IN RENAL TRANSPLANT
RECIPIENTS 391 MATTHEW R. WEIR, M.D. 20 INTERACTIONS OF THE ENDOTHELIUM
AND MESANGIUM IN GLOMERULAR INJURY: POTENTIAL ROLE OF CALCIUM
ANTAGONISTS 413 CHARLES SWEENEY, M.D. LEOPOLDO RAIJ, M.D. INDEX 427
|
| any_adam_object | 1 |
| building | Verbundindex |
| bvnumber | BV009261363 |
| callnumber-first | R - Medicine |
| callnumber-label | RC684 |
| callnumber-raw | RC684.C34 |
| callnumber-search | RC684.C34 |
| callnumber-sort | RC 3684 C34 |
| callnumber-subject | RC - Internal Medicine |
| classification_rvk | XI 4300 |
| ctrlnum | (OCoLC)28510750 (DE-599)BVBBV009261363 |
| dewey-full | 616.1/061 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.1/061 |
| dewey-search | 616.1/061 |
| dewey-sort | 3616.1 261 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01522nam a2200409 c 4500</leader><controlfield tag="001">BV009261363</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">940324s1992 d||| |||| 00||| engod</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1560530219</subfield><subfield code="9">1-56053-021-9</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)28510750</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV009261363</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield><subfield code="a">DE-11</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC684.C34</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.1/061</subfield><subfield code="2">20</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XI 4300</subfield><subfield code="0">(DE-625)153005:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Calcium antagonists in clinical medicine</subfield><subfield code="c">Murray Epstein</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Philadelphia</subfield><subfield code="b">Hanley & Belfus u.a.</subfield><subfield code="c">1992</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">VIII, 438 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Calciumantagonisten</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Klinische geneeskunde</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Calcium Channel Blockers</subfield><subfield code="x">metabolism</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Calcium Channel Blockers</subfield><subfield code="x">therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Calcium</subfield><subfield code="x">Antagonists</subfield><subfield code="x">Therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Heart Diseases</subfield><subfield code="x">drug therapy</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Calciumantagonist</subfield><subfield code="0">(DE-588)4069807-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Calciumantagonist</subfield><subfield code="0">(DE-588)4069807-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Epstein, Murray</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">GBV Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=006163051&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-006163051</subfield></datafield></record></collection> |
| id | DE-604.BV009261363 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T17:34:05Z |
| institution | BVB |
| isbn | 1560530219 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-006163051 |
| oclc_num | 28510750 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR DE-11 |
| owner_facet | DE-355 DE-BY-UBR DE-11 |
| physical | VIII, 438 S. graph. Darst. |
| publishDate | 1992 |
| publishDateSearch | 1992 |
| publishDateSort | 1992 |
| publisher | Hanley & Belfus u.a. |
| record_format | marc |
| spelling | Calcium antagonists in clinical medicine Murray Epstein Philadelphia Hanley & Belfus u.a. 1992 VIII, 438 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier Calciumantagonisten gtt Klinische geneeskunde gtt Calcium Channel Blockers metabolism Calcium Channel Blockers therapeutic use Calcium Antagonists Therapeutic use Heart Diseases drug therapy Calciumantagonist (DE-588)4069807-5 gnd rswk-swf Calciumantagonist (DE-588)4069807-5 s DE-604 Epstein, Murray Sonstige oth GBV Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=006163051&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Calcium antagonists in clinical medicine Calciumantagonisten gtt Klinische geneeskunde gtt Calcium Channel Blockers metabolism Calcium Channel Blockers therapeutic use Calcium Antagonists Therapeutic use Heart Diseases drug therapy Calciumantagonist (DE-588)4069807-5 gnd |
| subject_GND | (DE-588)4069807-5 |
| title | Calcium antagonists in clinical medicine |
| title_auth | Calcium antagonists in clinical medicine |
| title_exact_search | Calcium antagonists in clinical medicine |
| title_full | Calcium antagonists in clinical medicine Murray Epstein |
| title_fullStr | Calcium antagonists in clinical medicine Murray Epstein |
| title_full_unstemmed | Calcium antagonists in clinical medicine Murray Epstein |
| title_short | Calcium antagonists in clinical medicine |
| title_sort | calcium antagonists in clinical medicine |
| topic | Calciumantagonisten gtt Klinische geneeskunde gtt Calcium Channel Blockers metabolism Calcium Channel Blockers therapeutic use Calcium Antagonists Therapeutic use Heart Diseases drug therapy Calciumantagonist (DE-588)4069807-5 gnd |
| topic_facet | Calciumantagonisten Klinische geneeskunde Calcium Channel Blockers metabolism Calcium Channel Blockers therapeutic use Calcium Antagonists Therapeutic use Heart Diseases drug therapy Calciumantagonist |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=006163051&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| work_keys_str_mv | AT epsteinmurray calciumantagonistsinclinicalmedicine |